Long-term outcomes of esophageal and gastric cancer patients with cardiovascular and metabolic diseases: A two-center propensity score-matched cohort study

Figures

• 

  Figure 1. Diagram of the study design. CVMDs: cardiovascular and metabolic diseases.

• 

  Figure 2. Standardized differences in baseline characteristics between cancer patients with and without CVMD, before and after propensity score matching. CVMDs: cardiovascular and metabolic diseases.

• 

  Figure 3. Survival time of esophageal and gastric cancer patients with or without ischemic heart disease. Kaplan–Meier survival plots of cancer patients with or without ischemic heart disease before (A) and after matching (B). P values were calculated using the log-rank test. “No” refers to the group of cancer patients without ischemic heart disease, and “Yes” refers to the group of cancer patients with ischemic heart disease.